Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Buy
108,789
+83,594
+332% +$9.65M 0.07% 317
2026
Q1
$3.01M Sell
25,195
-11,767
-32% -$1.54M 0.02% 874
2025
Q4
$5.03M Buy
36,962
+2,720
+8% +$391K 0.09% 255
2025
Q3
$5.05M Buy
34,242
+14,852
+77% +$2.06M 0.05% 477
2025
Q2
$2.51M Buy
19,390
+10,712
+123% +$1.3M 0.03% 719
2025
Q1
$1.04M Buy
8,678
+3,120
+56% +$387K 0.01% 979
2024
Q4
$645K Buy
5,558
+683
+14% +$86.3K 0.01% 1085
2024
Q3
$658K Buy
4,875
+188
+4% +$25.2K 0.01% 1017
2024
Q2
$636K Buy
4,687
+859
+22% +$117K 0.01% 987
2024
Q1
$495K Buy
3,828
+940
+33% +$114K 0.01% 1080
2023
Q4
$330K Buy
2,888
+405
+16% +$40.4K 0.01% 1088
2023
Q3
$226K Buy
+2,483
New +$256K 0.01% 1121

Other funds holding XYL

Empowered Funds's XYL Position: Q2 2026 in Review

Empowered Funds increased its Xylem (XYL) stake by 332% in Q2 2026, buying an estimated $9.65M and bringing the position to 108,789 shares worth $12.9M. The position accounts for 0.07% of the portfolio, ranked #317.

Empowered Funds first reported a position in XYL in Q3 2023 and has held it in 12 quarters since. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Empowered Funds held 108,789 shares of Xylem worth $12.9M as of Q2 2026.
  • Empowered Funds bought 83,594 Xylem shares in Q2 2026, an estimated $9.65M.
  • Xylem made up 0.07% of Empowered Funds's portfolio in Q2 2026, its #317 holding.
  • Empowered Funds first reported a position in Xylem in Q3 2023 and has held it in 12 quarters since.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.